药效评价Development of CVN424: A Selective and Novel GPR6 Inverse Agonist Effective in Models of Parkinson Disease.
期刊:The Journal of pharmacology and experimental therapeutics发表年份:2021作者:Nicola L Brice; Hans H Schiffer; Holger Monenschein; Victoria J Mulligan; Keith Page; Justin Powell; Xiao Xu; Toni Cheung; J Russell Burley; Huikai Sun; Louise Dickson; Sean T Murphy; Nidhi Kaushal; Steve Sheardown; Jason Lawrence; Yun Chen; Darian B
